206 related articles for article (PubMed ID: 7669638)
1. Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity.
Gómez MI; Azaña JM; Arranz I; Harto A; Ledo A
Br J Dermatol; 1995 Jul; 133(1):37-40. PubMed ID: 7669638
[TBL] [Abstract][Full Text] [Related]
2. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
[TBL] [Abstract][Full Text] [Related]
4. Treatment of psoriasis with polyethylene sheet bath PUVA.
Streit V; Wiedow O; Christophers E
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
[TBL] [Abstract][Full Text] [Related]
5. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of 8-methoxypsoralen following PUVA-bath photochemotherapy.
von Kobyletzki G; Hoffmann K; Kerscher M; Altmeyer P
Photodermatol Photoimmunol Photomed; 1998; 14(3-4):136-8. PubMed ID: 9779504
[TBL] [Abstract][Full Text] [Related]
8. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
Collins P; Rogers S
Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
Shephard SE; Schregenberger N; Dummer R; Panizzon RG
Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
[TBL] [Abstract][Full Text] [Related]
10. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
Neild VS; Scott LV
Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
[TBL] [Abstract][Full Text] [Related]
12. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
13. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
14. Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment.
Sakuntabhai A; Diffey BL; Farr PM
Br J Dermatol; 1995 Dec; 133(6):919-23. PubMed ID: 8547045
[TBL] [Abstract][Full Text] [Related]
15. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
16. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
Lowe NJ; Weingarten D; Bourget T; Moy LS
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
[TBL] [Abstract][Full Text] [Related]
17. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater.
Wainwright NJ; MacLeod TM; Ferguson J
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123
[TBL] [Abstract][Full Text] [Related]
18. Bath vs. oral psoralen plus ultraviolet A: is one more effective than the other?
Wolf P
Br J Dermatol; 2013 Sep; 169(3):492-3. PubMed ID: 24033156
[No Abstract] [Full Text] [Related]
19. Randomized double-blind comparative study of 8-methoxypsoralen bath plus UV-A treatment regimens.
Berroeta L; Man I; Dawe RS; Ferguson J; Ibbotson SH
Actas Dermosifiliogr; 2010 Oct; 101(8):729-30. PubMed ID: 20965019
[No Abstract] [Full Text] [Related]
20. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
